RenovoRx, Inc. (RNXT) stock
RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.12+0.08 (+7.69%)
Close on Nov 18, 2026Market cap $50.55MP/E –Yield –
RenovoRx net income
Net income is the profit left for shareholders after every expense, interest and tax.
RenovoRx's net income for the twelve months ending Jun 30, 2026 was -$12.29M. For fiscal 2025 it was -$11.17M. The highest annual figure on record is -$3.80M in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.17M | – |
| FY2024 | Dec 31, 2024 | -$8.81M | – |
| FY2023 | Dec 31, 2023 | -$10.23M | – |
| FY2022 | Dec 31, 2022 | -$9.89M | – |
| FY2021 | Dec 31, 2021 | -$6.32M | – |
| FY2020 | Dec 31, 2020 | -$3.80M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.91M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.52M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.94M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.91M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.90M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.42M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.88M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.47M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.39M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.08M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.23M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.42M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.33M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.26M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.16M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.14M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.59M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.00M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.36M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.51M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.31M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.15M | – |
| Q4 FY2020 | Dec 31, 2020 | -$878.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.10M | – |
| Q2 FY2020 | Jun 30, 2020 | -$773.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.05M | – |
See a number that looks wrong?